University Hospital for Visceral Surgery, Pius-Hospital, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
Institute for Pathology, Ruhr University Bochum, Bochum, Germany.
PLoS One. 2021 Mar 18;16(3):e0248633. doi: 10.1371/journal.pone.0248633. eCollection 2021.
Factors for overall survival after pancreatic ductal adenocarcinoma (PDAC) seem to be nodal status, chemotherapy administration, UICC staging, and resection margin. However, there is no consensus on the definition for tumor free resection margin. Therefore, univariate OS as well as multivariate long-term survival using cancer center data was analyzed with regards to two different resection margin definitions. Ninety-five patients met inclusion criteria (pancreatic head PDAC, R0/R1, no 30 days mortality). OS was analyzed in univariate analysis with respect to R-status, CRM (circumferential resection margin; positive: ≤1mm; negative: >1mm), nodal status, and chemotherapy administration. Long-term survival >36 months was modelled using multivariate logistic regression instead of Cox regression because the distribution function of the dependent data violated the requirements for the application of this test. Significant differences in OS were found regarding the R status (Median OS and 95%CI for R0: 29.8 months, 22.3-37.4; R1: 15.9 months, 9.2-22.7; p = 0.005), nodal status (pN0 = 34.7, 10.4-59.0; pN1 = 17.1, 11.5-22.8; p = 0.003), and chemotherapy (with CTx: 26.7, 20.4-33.0; without CTx: 9.7, 5.2-14.1; p < .001). OS according to CRM status differed on a clinically relevant level by about 12 months (CRM positive: 17.2 months, 11.5-23.0; CRM negative: 29.8 months, 18.6-41.1; p = 0.126). A multivariate model containing chemotherapy, nodal status, and CRM explained long-term survival (p = 0.008; correct prediction >70%). Chemotherapy, nodal status and resection margin according to UICC R status are univariate factors for OS after PDAC. In contrast, long-term survival seems to depend on wider resection margins than those used in UICC R classification. Therefore, standardized histopathological reporting (including resection margin size) should be agreed upon.
胰腺癌(PDAC)患者的总生存(OS)因素似乎包括淋巴结状态、化疗的应用、UICC 分期和切缘状态。然而,对于无肿瘤切缘的定义尚未达成共识。因此,我们使用癌症中心的数据,针对两种不同的切缘定义,对单因素 OS 以及多因素长期生存进行了分析。符合纳入标准的患者共 95 例(胰头 PDAC,R0/R1,无 30 天死亡率)。单因素 OS 分析中,我们研究了 R 状态、CRM(环周切缘;阳性:≤1mm;阴性:>1mm)、淋巴结状态和化疗的应用与 OS 的关系。由于依赖数据的分布函数违反了该检验的应用要求,因此我们使用多因素逻辑回归而不是 Cox 回归来建模 36 个月以上的长期生存。OS 方面的显著差异与 R 状态有关(R0 状态的中位 OS 和 95%CI 为 29.8 个月,22.3-37.4;R1 状态为 15.9 个月,9.2-22.7;p=0.005)、淋巴结状态(pN0=34.7,10.4-59.0;pN1=17.1,11.5-22.8;p=0.003)和化疗(有 CTx:26.7,20.4-33.0;无 CTx:9.7,5.2-14.1;p<0.001)。CRM 状态的 OS 差异在临床上有大约 12 个月的差异(CRM 阳性:17.2 个月,11.5-23.0;CRM 阴性:29.8 个月,18.6-41.1;p=0.126)。包含化疗、淋巴结状态和 CRM 的多因素模型可解释长期生存(p=0.008;正确预测率>70%)。化疗、淋巴结状态和 UICC R 状态下的切缘是 PDAC 患者 OS 的单因素。相比之下,长期生存似乎取决于比 UICC R 分类中更宽的切缘。因此,应商定标准化的组织病理学报告(包括切缘大小)。